Alison Moore

Insider Reports History

Entity
Individual
Location
C/O Allogene Therapeutics, Inc., 210 East Grand Avenue, South San Francisco, CA
Signature
/s/ Neha Krishnamohan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alison Moore:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. Chief Technical Officer Common Stock 673K $2.14M $3.17 Mar 22, 2023 Direct
CODEXIS, INC. Chief Technical Officer Common Stock 149K $425K $2.86 Oct 10, 2024 Direct
Allogene Therapeutics, Inc. Chief Technical Officer Stock Option (Right to buy) 433K Mar 22, 2023 Direct
CODEXIS, INC. Chief Technical Officer Stock Option (Right to Buy) 300K Oct 10, 2024 Direct
Artiva Biotherapeutics, Inc. Director Director Stock Option (Right to Buy) 27.5K Oct 21, 2024 Direct

Insider Reports Filed by Alison Moore

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ARTV Artiva Biotherapeutics, Inc. Oct 21, 2024 1 $0 4 Oct 22, 2024 Director
ARTV Artiva Biotherapeutics, Inc. Oct 21, 2024 0 $0 3 Oct 22, 2024 Director
CDXS CODEXIS, INC. Oct 10, 2024 2 $0 4 Oct 10, 2024 Chief Technical Officer
CDXS CODEXIS, INC. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
CDXS CODEXIS, INC. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
ALLO Allogene Therapeutics, Inc. Mar 22, 2023 2 $0 4 Mar 24, 2023 Chief Technical Officer
ALLO Allogene Therapeutics, Inc. Mar 14, 2023 1 -$46K 4 Mar 16, 2023 Chief Technical Officer
CDXS CODEXIS, INC. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
ALLO Allogene Therapeutics, Inc. Mar 23, 2022 1 $0 4 Mar 25, 2022 Chief Technical Officer
ALLO Allogene Therapeutics, Inc. Mar 15, 2022 1 -$66.4K 4 Mar 17, 2022 Chief Technical Officer
CDXS CODEXIS, INC. Jun 15, 2021 1 $0 4 Jun 17, 2021 Director